• 1
    Williams VSL, Baldwin DS, Hogue S et al. Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in two European countries: a cross-sectional patient survey. J Clin Psychiatry 2006; 67: 20410
  • 2
    Balon R. SSRI-associated sexual dysfunction. Am J Psychiatry 2006; 163: 15049
  • 3
    Safarinejad MR. Prevalence and risk factors for erectile dysfunction in a population-based study in Iran. Int J Impot Res 2003; 15: 24652
  • 4
    Montgomery SA, Baldwin DS, Riley A. Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction. J Affect Disord 2002; 69: 11940
  • 5
    National Ambulatory Care Medical Survey. 1997 summary. Adv Data 1999; 305: 128
  • 6
    Lane RM. A critical review of selective serotonin reuptake inhibitor-related sexual dysfunction: incidence, possible aetiology and implications for management. J Psychopharmacol 1997; 11: 7282
  • 7
    Nurnberg HG. An evidence-based review updating the various treatment and management approaches to serotonin reuptake inhibitor-associated sexual dysfunction. Drugs Today (Barc) 2008; 44: 14768
  • 8
    Meston CM. A randomized, placebo-controlled, crossover study of ephedrine for SSRI-induced female sexual dysfunction. J Sex Marital Ther 2004; 30: 5768
  • 9
    Safarinejad MR. Evaluation of endocrine profile and hypothalamic-pituitary-testis axis in selective serotonin reuptake inhibitor-induced male sexual dysfunction. J Clin Psychopharmacol 2008; 28: 41823
  • 10
    Masand PS, Ashton AK, Gupta S et al. Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study. Am J Psychiatry 2001; 158: 8057
  • 11
    Nurnberg HG, Hensley PL, Gelenberg AJ et al. Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial. JAMA 2003; 289: 5664
  • 12
    Segraves RT, Lee J, Stevenson R et al. Tadalafil for treatment of erectile dysfunction in men on antidepressants. J Clin Psychopharmacol 2007; 27: 626
  • 13
    Safarinejad MR, Hosseini SY. Salvage of sildenafil failures with bremelanotide: a randomized, double-blind, placebo controlled study. J Urol 2008; 179: 106671
  • 14
    Atkinson JH, Slater MA, Wahlgren DR et al. Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity. Pain 1999; 83: 13745
  • 15
    Wilens TE, Haight BR, Horrigan JP et al. Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. Biol Psychiatry 2005; 57: 793801
  • 16
    Segraves RT, Clayton A, Croft H et al. Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J Clin Psychopharmacol 2004; 24: 33942
  • 17
    Clayton AH. Female sexual dysfunction related to depression and antidepressant medications. Curr Womens Health Rep 2002; 2: 1827
  • 18
    Stahl SM, Pradko JF, Haight BR et al. A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim Care Companion J Clin Psychiatry 2004; 6: 15966
  • 19
    Clayton AH, Warnock JK, Kornstein SG et al. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 2004; 65: 627
  • 20
    DeBattista C, Solvason B, Poirier J et al. A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction. J Clin Psychiatry 2005; 66: 8448
  • 21
    Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 5662
  • 22
    Frank E, Prien RF, Jarrett RB et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991; 48: 8515
  • 23
    Rosen R, Riley A, Wagner G et al. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 82230
  • 24
    Guy W. ECDEU Assessment Manual for Psychopharmacology. Washington: National Institute of Mental Health, US Department of Health, Education, and Welfare, 1976
  • 25
    McGahuey CA, Gelenberg AJ, Laukes CA et al. The Arizona Sexual Experience Scale (ASEX): reliability and validity. J Sex Marital Ther 2000; 26: 2540
  • 26
    Althof SE, Corty EW, Levine SB et al. EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology 1999; 53: 7939
  • 27
    Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32: 505
  • 28
    Murray JB. Physiological mechanisms of sexual dysfunction side effects associated with antidepressant medication. J Psychol 1998; 132: 40716
  • 29
    Aukst-Margetiinline image B, Margetiinline image B. An open-label series using loratadine for the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 7546
  • 30
    Ramasubbu R. Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression. J Psychiatry Neurosci 1999; 24: 4550
  • 31
    Herrera-Guzmán I, Gudayol-Ferré E, Lira-Mandujano J et al. Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder. Psychiatry Res 2008; 160: 7282
  • 32
    Paredes RG, Agmo A. Has dopamine a physiological role in the control of sexual behavior? A critical review of the evidence. Prog Neurobiol 2004; 73: 179226
  • 33
    Viitamaa T, Haapalinna A, Agmo A. The adrenergic alpha2 receptor and sexual incentive motivation in male rats. Pharmacol Biochem Behav 2006; 83: 3609
  • 34
    Montejo-González AL, Llorca G, Izquierdo JA et al. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther 1997; 23: 17687
  • 35
    Clayton A, Keller A, McGarvey EL. Burden of phase-specific sexual dysfunction with SSRIs. J Affect Disord 2006; 91: 2732
  • 36
    Landén M, Eriksson E, Agren H et al. Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 1999; 19: 26871
  • 37
    Jespersen S, Berk M, Van Wyk C et al. A pilot randomized, double-blind, placebo-controlled study of granisetron in the treatment of sexual dysfunction in women associated with antidepressant use. Int Clin Psychopharmacol 2004; 19: 1614
  • 38
    Michelson D, Bancroft J, Targum S et al. Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention. Am J Psychiatry 2000; 157: 23943
  • 39
    Balon R, Yeragani VK, Pohl R et al. Sexual dysfunction during antidepressant treatment. J Clin Psychiatry 1993; 554: 20912